Cable Car Capital, LP
Cable Car's Jacob Ma-Weaver joins Mayne Pharma board
Summary: Mayne Pharma Group Limited announced through an ASX release that Jacob Ma-Weaver accepted an invitation to join its board as a non-executive director, effective 14 August 2026. The announcement identifies Ma-Weaver as Managing Member of Cable Car Capital, LP, says Cable Car is general partner of Funicular Funds, LP, and states that Funicular held 9.90% of Mayne Pharma at the announcement date.
Why it matters: For due-diligence readers, the appointment is a public governance and concentrated-holder monitoring signal involving a Cable Car-linked principal, while the source support should not be stretched into claims about control, board agenda, future corporate action, valuation, investment recommendation, or investment merit.
Summary
Mayne Pharma Group Limited announced through an ASX release that Jacob Ma-Weaver accepted an invitation to join its board as a non-executive director, effective 14 August 2026. The announcement identifies Ma-Weaver as Managing Member of Cable Car Capital, LP, an investment adviser he founded in 2013.
The same announcement says Cable Car is the general partner of Funicular Funds, LP, and states that Funicular held 9.90% of Mayne Pharma’s fully paid ordinary shares at the announcement date. This draft treats those facts as official company-source context and avoids inferring control, strategy, board agenda, or transaction intent beyond the announcement.
Why it matters
For due-diligence readers, a board appointment tied to a named investment adviser principal can be a useful governance-monitoring signal. It may help readers track public-company board composition, holder-to-board pathways, and how manager-linked principals appear in issuer disclosures.
The source support is still narrow. The announcement does not establish Cable Car control of Mayne Pharma, predict any future corporate action, validate an investment thesis, provide a valuation view, or support an investment recommendation. Those conclusions should not be inferred from the board appointment or the 9.90% holder statement.
Source notes
- Mayne Pharma ASX announcement: https://announcements.asx.com.au/asxpdf/20260805/pdf/072fzvf2yyy8zx.pdf
- Cable Car Capital official site for adviser/general-partner identity: http://www.cablecarcapital.com/
- SEC Investment Adviser Public Disclosure firm summary for Cable Car Capital, LP: https://adviserinfo.sec.gov/firm/summary/169234
- Latest public Form ADV PDF for Cable Car Capital, LP: https://reports.adviserinfo.sec.gov/reports/ADV/169234/PDF/169234.pdf
- Mayne Pharma directors and senior leadership page: https://www.maynepharma.com/about-us/senior-leadership-directors
- Source posture: official ASX/company announcement and company leadership page for the board appointment, with Cable Car, IAPD, and public Form ADV sources for manager/adviser identity. The ASX announcement should control the effective date, Cable Car/Funicular wording, and 9.90% holder statement.
9AT filing context
Public adviser/Form ADV context can identify Cable Car Capital, LP as CIK 1699575, CRD 169234, and SEC file 801-127894. The latest public Form ADV reviewed for this draft reports $548,315,000 in regulatory assets under management.
That context is suitable only for entity identity and background. Cable Car’s public 13F history was not used as a standalone news hook and should not be used here to imply current exposure, total AUM, performance, control, or investment merit. No Form 5500 context was recommended for this item.
What to watch
Watch for later Mayne Pharma board materials, ASX announcements, holder notices, meeting materials, or Cable Car/Funicular public filings that clarify Ma-Weaver’s board role, any committee assignments, changes in Funicular’s reported holding, or any formally disclosed governance actions.